CHAMPIONS ONCOLOGY INC
For the period ended Apr 30, 2024. Filed Jul 19, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Jul 19, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 16. Form 10-K Summary
Not Required.
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| CHAMPIONS ONCOLOGY, INC. | |
| July 19, 2024 | /s/ RONNIE MORRIS |
|---|---|
| Ronnie Morris | |
| Chief Executive Officer | |
| (principal executive officer) |
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| Signature | Title | Date |
|---|---|---|
| /s/ RONNIE MORRIS | Chief Executive Officer and Director | July 19, 2024 |
| Ronnie Morris | (principal executive officer) | |
| /s/ DAVID MILLER | Chief Financial Officer | July 19, 2024 |
| David Miller | (principal financial and accounting officer) | |
| /s/ JOEL ACKERMAN | Director, | July 19, 2024 |
| Joel Ackerman | Chairman of the Board of Directors | |
| /s/ DAVID SIDRANSKY | Director | July 19, 2024 |
| David Sidransky | ||
| /s/ ROBERT BRAININ | Director | July 19, 2024 |
| Robert Brainin | ||
| /s/ SCOTT R. TOBIN | Director | July 19, 2024 |
| Scott R. Tobin | ||
| /s/ DANIEL MENDELSON | Director | July 19, 2024 |
| Daniel Mendelson | ||
| /s/ PHILIP BREITFELD | Director | July 19, 2024 |
| Philip Breitfeld | ||
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
| Report of Independent Registered Public Accounting Firm (PCAOB ID# 274) | F-2 |
|---|---|
| Consolidated Balance Sheets | F-4 |
| Consolidated Statements of Operations | F-5 |
| Consolidated Statements of Changes in Stockholders' (Deficiency) Equity | F-6 |
| Consolidated Statements of Cash Flows | F-7 |
| Notes to Consolidated Financial Statements | F-8 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.